PE20030732A1 - USE OF ALKYLPHOSPHOCOLINS IN THE PREVENTIVE TREATMENT OF DISEASES CAUSED BY PROTOZOARIANS - Google Patents

USE OF ALKYLPHOSPHOCOLINS IN THE PREVENTIVE TREATMENT OF DISEASES CAUSED BY PROTOZOARIANS

Info

Publication number
PE20030732A1
PE20030732A1 PE2003000061A PE2003000061A PE20030732A1 PE 20030732 A1 PE20030732 A1 PE 20030732A1 PE 2003000061 A PE2003000061 A PE 2003000061A PE 2003000061 A PE2003000061 A PE 2003000061A PE 20030732 A1 PE20030732 A1 PE 20030732A1
Authority
PE
Peru
Prior art keywords
diseases caused
protozoarians
alkylphosphocolins
treatment
preventive treatment
Prior art date
Application number
PE2003000061A
Other languages
Spanish (es)
Inventor
Jurgen Engel
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PE20030732A1 publication Critical patent/PE20030732A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO EN MAMIFEROS, DE ENFERMEDADES CAUSADAS POR PROTOZOARIOS, EN PARTICULAR LEISHMANIASIS, LA CUAL CONTIENE a)ALQUILFOSFOCOLINA, EN PARTICULAR HEXADECILFOSFOCOLINA (MILTEFOSINA) o FOSFATO DE OCTADECIL-(1,1-DIMETIL-PIPERIDINIO-4-ILO) (PERIFOSINA); b)UN ANTIEMETICO Y/O UN ANTIDIARREICO. SE REFIERE TAMBIEN AL EMPLEO DE ALQUILFOSFOCOLINAS PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO YA DESCRITO Y A UN ESQUEMA DE DOSIFICACION DE LA COMPOSICION PARA DICHO TRATAMIENTOREFERS TO A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT IN MAMMALS, OF DISEASES CAUSED BY PROTOZOARIES, IN PARTICULAR LEISHMANIASIS, WHICH CONTAINS a) ALKYLPHOSPHOCOLINE, IN PARTICULAR HEXADECILPHOSPHOCOLINE (1,1-PHYPTEPHOSADETILE-4-OXYPTEPHOSADETILE-DIMETHYL-4-MILTHYPTEPHOSADE -ILO) (PERIPHOSINE); b) AN ANTIEMETIC AND / OR AN ANTIDIARRHEAL. IT ALSO REFERS TO THE USE OF ALKYLPHOSPHOCOLINES FOR THE PREPARATION OF A DRUG FOR THE TREATMENT ALREADY DESCRIBED AND TO A DOSAGE SCHEME OF THE COMPOSITION FOR SUCH TREATMENT

PE2003000061A 2002-01-25 2003-01-20 USE OF ALKYLPHOSPHOCOLINS IN THE PREVENTIVE TREATMENT OF DISEASES CAUSED BY PROTOZOARIANS PE20030732A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (en) 2002-01-25 2002-01-25 Use of alkylphosphocholines in the preventive treatment of protozoal diseases

Publications (1)

Publication Number Publication Date
PE20030732A1 true PE20030732A1 (en) 2003-09-27

Family

ID=7713213

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000061A PE20030732A1 (en) 2002-01-25 2003-01-20 USE OF ALKYLPHOSPHOCOLINS IN THE PREVENTIVE TREATMENT OF DISEASES CAUSED BY PROTOZOARIANS

Country Status (16)

Country Link
EP (1) EP1467742A1 (en)
JP (1) JP2005515244A (en)
CN (1) CN1622811A (en)
AR (1) AR038224A1 (en)
AU (1) AU2003236787B2 (en)
BR (1) BR0307021A (en)
CA (1) CA2470185A1 (en)
CO (1) CO5601024A2 (en)
DE (1) DE10203195A1 (en)
IL (2) IL162492A0 (en)
MX (1) MXPA04007193A (en)
NZ (1) NZ548040A (en)
PE (1) PE20030732A1 (en)
TW (1) TWI339582B (en)
WO (1) WO2003061669A1 (en)
ZA (1) ZA200404690B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (en) * 2005-02-23 2007-10-15 Obwaller Andreas Dr CLEANING AGENT FOR CONTACT LENSES
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
AU2006328479B2 (en) * 2005-12-19 2012-03-08 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
CN104473941A (en) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 Miltefosine-containing medicine preparation and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132344A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft METHOD FOR PRODUCING A MEDAL FOR ORAL OR TOPICAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIASIS
DE4132345A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Medicament compsns. for intravenous admin. of lytic agents - used for treatment of tumours, auto-immune disorders, multiple sclerosis, etc.
AU682464B2 (en) * 1992-03-06 1997-10-09 Lica Pharmaceuticals A/S Treatment and prophylaxis of diseases caused by parasites, or bacteria
PT1051159E (en) * 1998-01-22 2002-09-30 Zentaris Ag SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING MILTEFOSIN FOR ORAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIOSE
DE10020812C2 (en) * 2000-04-20 2003-06-26 Robert Koch Inst Use of naphthindazole-4,9-quinones as antiparasitic agents
AU2002232400A1 (en) * 2000-11-06 2002-05-15 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
TWI339582B (en) 2011-04-01
WO2003061669A1 (en) 2003-07-31
JP2005515244A (en) 2005-05-26
AU2003236787B2 (en) 2007-03-22
MXPA04007193A (en) 2004-10-29
TW200302103A (en) 2003-08-01
IL162492A (en) 2009-12-24
IL162492A0 (en) 2005-11-20
DE10203195A1 (en) 2003-08-07
ZA200404690B (en) 2004-09-27
CN1622811A (en) 2005-06-01
EP1467742A1 (en) 2004-10-20
NZ548040A (en) 2007-06-29
CA2470185A1 (en) 2003-07-31
AR038224A1 (en) 2005-01-05
CO5601024A2 (en) 2006-01-31
BR0307021A (en) 2004-11-03

Similar Documents

Publication Publication Date Title
ECSP045069A (en) USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
CY1116463T1 (en) Combination therapy for the therapeutic treatment of Protein Deficiency Disorders
IS2517B (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
BRPI0418251B8 (en) phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them
AR047841A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE-INFLAMMATORY DISORDERS
ATE486587T1 (en) FORMULATIONS FOR THE ORAL ADMINISTRATION OF ACTIVE INGREDIENTS
ES2340502T3 (en) COMPOUNDS OF 1,4,8-TRIAZAESPIRO (4,5) DECAN-2-ONA SUBSTITUTED FOR THE TREATMENT OF OBESITY.
UY28041A1 (en) LOW DOSE METHODS FOR THE TREATMENT OF DISORDERS IN WHICH TNFA'S ACTIVITY IS HARMFUL.
DK1781277T3 (en) Combination composition comprising Ibuprofen and Paracetamol
DOP2002000429A (en) IMIDAZOTRIAZINAS
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
AR109263A2 (en) COMPOSITION INCLUDING MOXIDECTINE
EA200400664A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING METHFORMIN AND GLIBENCLAMIDE, APPLIED TO THE TREATMENT OF TYPE II DIABETES
PT1506185E (en) NEW COMPOUNDS AND THEIR UTILIZATION
UY27296A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ATE499939T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
BR9916575A (en) Pharmaceutical composition of controlled release with tilidine mesylate as active substance
CO5190674A1 (en) TREATMENT OF NEUROTIC DISORDERS NEUROTIC DISORDERS
EA200500764A1 (en) PHARMACEUTICAL COMPOSITIONS AND MEDICAL FORMS FOR TRANSBUCCAL AND SUBLINGUAL DELIVERY TIZANIDINE AND METHODS OF INTRODUCTION TIZANIDINE SUBLINGUAL OR TRANSBUCKAL
CL2004000765A1 (en) INTRANASAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOSITE DERIVED FROM 8,9-DIOXO-2,6-DIAZABICICLO.
PE20030732A1 (en) USE OF ALKYLPHOSPHOCOLINS IN THE PREVENTIVE TREATMENT OF DISEASES CAUSED BY PROTOZOARIANS
EA200501231A1 (en) APPLICATION OF DIPYRIDAMOL IN COMBINATION WITH ACETYLSALICYLIC ACID AND ANTAGONIST ANGIOTENZIN II FOR PREVENTION OF STROKE

Legal Events

Date Code Title Description
FC Refusal